Anti-Retrovirals for Kaposi's Sarcoma (ARKS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by University of California, San Francisco.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Gilead Sciences
Abbott
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00444379
First received: March 6, 2007
Last updated: February 24, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)